Skip to content

Corporate
- Pitch
- Mission
- CSR
- Team
Technology
Pipeline
Clinical trials
Newsroom
Partnerships

Home
Corporate
- Pitch
- Mission
- CSR
- Team
Technology
Pipeline
Clinical trials
Newsroom
Partnerships
Contact

C

1 min read

[Newsletter -3] NEWS/INFOS

Author Bertrand Fabien
Published 15 mai 2020

May 15, 2020.

>> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<

Download our newsletter (english version)
Télécharger notre newsletter (version française)

Related Posts

Reflections on #AACR2024: our key insights and contributions

April, 2024. The AACR Annual Meeting in San Diego was a pivotal...

XENOTHERA announces the start of the second dose cohort in the FIPO trial

March, 2024. FIPO is the first-in-human trial of XON7, the first anti-solid...

XENOTHERA : publication of the first-in-human trial of LIS1 in Solid Organ Transplantation

February, 2024. For almost ten years, XENOTHERA has been committed to tackling...

Corporate
Technology
Pipeline

Clinical trials
Newsroom
Partnerships

Contact
Legal notice

XENOTHERA

21 rue La Nouë de Fer, 44200 Nantes, France

contact@xenothera.com

Media : xenothera@izsogood.co